Covered recipient · General Payments record
GABRIEL J YOUNG
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$10,365.80
- Reported across 275 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,521.04 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| IBSA Pharma Inc. | $375.57 | 8 |
| Amgen Inc. | $292.25 | 4 |
| Teva Pharmaceuticals USA, Inc. | $254.26 | 2 |
| Lilly USA, LLC | $154.10 | 1 |
| GlaxoSmithKline, LLC. | $149.94 | 2 |
| Gilead Sciences, Inc. | $144.56 | 6 |
| SK Life Science, Inc. | $79.34 | 1 |
| PFIZER INC. | $42.58 | 2 |
| ABBVIE INC. | $28.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.44 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106380638 | CMS |
| Amgen Inc. | $20.97 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111744978 | CMS |
| Amgen Inc. | $123.51 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111744980 | CMS |
| Amgen Inc. | $22.78 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117421016 | CMS |
| Amgen Inc. | $124.99 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117421018 | CMS |
| Gilead Sciences, Inc. | $26.08 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768775 | CMS |
| Gilead Sciences, Inc. | $27.50 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768777 | CMS |
| Gilead Sciences, Inc. | $8.03 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768779 | CMS |
| Gilead Sciences, Inc. | $23.92 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768781 | CMS |
| Gilead Sciences, Inc. | $27.33 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768783 | CMS |
| Gilead Sciences, Inc. | $31.70 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768785 | CMS |
| GlaxoSmithKline, LLC. | $27.84 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116456891 | CMS |
| GlaxoSmithKline, LLC. | $122.10 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116270894 | CMS |
| IBSA Pharma Inc. | $22.26 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142982528 | CMS |
| IBSA Pharma Inc. | $19.31 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142982530 | CMS |
| IBSA Pharma Inc. | $125.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142976884 | CMS |
| IBSA Pharma Inc. | $19.57 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142982532 | CMS |
| IBSA Pharma Inc. | $20.40 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142982534 | CMS |
| IBSA Pharma Inc. | $125.00 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142977154 | CMS |
| IBSA Pharma Inc. | $21.78 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974781 | CMS |
| IBSA Pharma Inc. | $22.25 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142976532 | CMS |
| Lilly USA, LLC | $154.10 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134977026 | CMS |
| PFIZER INC. | $23.29 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131295959 | CMS |
| PFIZER INC. | $19.29 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131275923 | CMS |
| SK Life Science, Inc. | $79.34 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154120705 | CMS |
| Teva Pharmaceuticals USA, Inc. | $122.94 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151711131 | CMS |
| Teva Pharmaceuticals USA, Inc. | $131.32 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151711133 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.